Cargando…
RGFP966 Suppresses Tumor Growth and Migration Through Inhibition of EGFR Expression in Hepatocellular Carcinoma Cells in vitro
PURPOSE: Histone deacetylase 3 (HDAC3) has been suggested to play a role in hepatocellular carcinoma (HCC). In the present report, we aimed to identify the effects of RGFP966, a specific HDAC3 inhibitor, on the cell proliferation and migration of HCC cell lines. METHODS: Human HCC cell lines, which...
Autores principales: | Yu, Xinying, Yang, Fan, Jiang, Hong, Fan, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959505/ https://www.ncbi.nlm.nih.gov/pubmed/32021097 http://dx.doi.org/10.2147/DDDT.S234871 |
Ejemplares similares
-
HDAC3 Inhibitor RGFP966 Modulates Neuronal Memory for Vocal Communication Signals in a Songbird Model
por: Phan, Mimi L., et al.
Publicado: (2017) -
RGFP966 exerts neuroprotective effect via HDAC3/Nrf2 pathway after surgical brain injury in rats
por: Gu, Hai-Ping, et al.
Publicado: (2023) -
HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity
por: Leus, Niek G.J., et al.
Publicado: (2016) -
COLLABORATION AGREEMENT No. K 966
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2003) -
The Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinction
por: Bowers, Mallory E., et al.
Publicado: (2015)